Abstract: A method for quantifying glycated hemoglobin (HbA1c) contained in a sample, the method including: (a) a process for mixing the sample with a protease in the presence of a composition of a cationic surfactant and a tetrazolium salt to obtain an aqueous glycated peptide solution containing a glycated peptide; (b) a process for mixing the aqueous glycated peptide solution obtained in process (a) with a fructosyl peptide oxidase to obtain hydrogen peroxide, the aqueous glycated peptide solution here containing the composition; and (c) a process for calculating the concentration of the glycated hemoglobin (HbA1c) on the basis of the amount of hydrogen peroxide solution obtained in process (b).

Abstract: A plasma display device having a panel main body in which a pair of transparent substrates is arranged in opposition so as to form a discharge space between the substrates on at least a front side, barrier ribs are arranged on at least one of the substrates to divide the discharge space into a plurality of spaces, a group of electrodes is arranged on the substrates so as to generate discharge in the discharge space divided with the barrier ribs, and phosphor layers that emit by discharge are provided, in which the phosphor layers are equipped with a green phosphor layer including at least Zn2SiO4:Mn, a surface of Zn2SiO4:Mn is coated with magnesium oxide, and a ratio of an Mg element to a Si element on the surface measured with an XPS apparatus is 0.7 to 4.0.

Abstract: A plasma display device has a panel main body in which a pair of transparent substrates is arranged in opposition so as to form a discharge space between the substrates on at least a front side. Barrier ribs are arranged on at least one of the substrates to divide the discharge space into a plurality of spaces. A group of electrodes is arranged on the substrates so as to generate discharge in the discharge space divided with the barrier ribs. Phosphor layers that emit by discharge are also provided. The phosphor layers are equipped with a green phosphor layer including at least Zn2SiO4:Mn, a surface of Zn2SiO4:Mn is coated with aluminum oxide, and a ratio of an Al element to a Si element on the surface measured with an XPS apparatus is 0.6 to 4.0.

Abstract: A plasma display device having a panel main body in which a pair of transparent substrates is arranged in opposition so as to form a discharge space between the substrates on at least a front side, barrier ribs are arranged on at least one of the substrates to divide the discharge space into a plurality of spaces, a group of electrodes is arranged on the substrates so as to generate discharge in the discharge space divided with the barrier ribs, and phosphor layers that emit by discharge are provided, in which the phosphor layers are equipped with a green phosphor layer including at least a mixture of Zn2SiO4:Mn and (Y, Gd)BO3:Tb, the surface of the Zn2SiO4:Mn is coated with aluminum oxide, and the ratio of the Al element to the Si element on the surface measured with an XPS apparatus is 0.6 to 7.0.

Abstract: A plasma display device having a panel main body in which a pair of transparent substrates is arranged in opposition so as to form a discharge space between the substrates on at least a front side, barrier ribs are arranged on at least one of the substrates to divide the discharge space into a plurality of spaces, a group of electrodes is arranged on the substrates so as to generate discharge in the discharge space divided with the barrier ribs, and phosphor layers that emit by discharge are provided, in which the phosphor layers are equipped with a green phosphor layer including at least a mixture of Zn2SiO4:Mn and (Y, Gd)BO3:Tb, the surface of the Zn2SiO4:Mn is coated with magnesium oxide, and the ratio of the Mg element to the Si element on the surface measured with an XPS apparatus is 0.7 to 6.0.

Abstract: A method for producing a front panel of a plasma display panel wherein an electrode, a dielectric layer and a protective layer are formed on a substrate of the front panel, a formation of the protective layer comprising the steps of: (i) forming a first protective layer by sputtering or vapor deposition process on a dielectric layer of a substrate; (ii) applying a MgO material onto the first protective layer to form a MgO material layer; and (iii) drying the Mgo material layer so as to form a second protective layer therefrom, wherein the MgO material comprises a MgO powder, a solvent A and a solvent B; a vapor pressure of the solvent A is higher than and equal to 50 Pa at 20° C.; a vapor pressure of the solvent B is lower than and equal to 7 Pa at 20° C.; and a proportion of the solvent B to all solvents contained in the MgO material is higher than and equal to 3% by weight.

Abstract: A specific coupling reaction measuring method of this invention for measuring a content of a subject substance in a sample includes the steps of (a) constructing a reaction system including the sample and a magnetic particle on which a specific coupling substance for specifically coupling with the subject substance is immobilized; (b) measuring an optical characteristic of the reaction system; and (c) removing, from the reaction system, an agglutination complex including the subject substance, the specific coupling substance and the magnetic particle by utilizing magnetic force.

Abstract: A plasma display device having a panel main body in which a pair of transparent substrates is arranged in opposition so as to form a discharge space between the substrates on at least a front side, barrier ribs are arranged on at least one of the substrates to divide the discharge space into a plurality of spaces, a group of electrodes is arranged on the substrates so as to generate discharge in the discharge space divided with the barrier ribs, and phosphor layers that emit by discharge are provided, in which the phosphor layers are equipped with a green phosphor layer including at least a mixture of Zn2SiO4:Mn and (Y, Gd)BO3:Tb, the surface of the Zn2SiO4:Mn is coated with magnesium oxide, and the ratio of the Mg element to the Si element on the surface measured with an XPS apparatus is 0.7 to 6.0.

Abstract: A plasma display device having a panel main body in which a pair of transparent substrates is arranged in opposition so as to form a discharge space between the substrates on at least a front side, barrier ribs are arranged on at least one of the substrates to divide the discharge space into a plurality of spaces, a group of electrodes is arranged on the substrates so as to generate discharge in the discharge space divided with the barrier ribs, and phosphor layers that emit by discharge are provided, in which the phosphor layers are equipped with a green phosphor layer including at least a mixture of Zn2SiO4: Mn and (Y, Gd)BO3: Tb, the surface of the Zn2SiO4: Mn is coated with aluminum oxide, and the ratio of the Al element to the Si element on the surface measured with an XPS apparatus is 0.6 to 7.0.

Abstract: A plasma display device having a panel main body in which a pair of transparent substrates is arranged in opposition so as to form a discharge space between the substrates on at least a front side, barrier ribs are arranged on at least one of the substrates to divide the discharge space into a plurality of spaces, a group of electrodes is arranged on the substrates so as to generate discharge in the discharge space divided with the barrier ribs, and phosphor layers that emit by discharge are provided, in which the phosphor layers are equipped with a green phosphor layer including at least Zn2SiO4:Mn, a surface of Zn2SiO4:Mn is coated with aluminum oxide, and a ratio of an Al element to a Si element on the surface measured with an XPS apparatus is 0.6 to 4.0.

Abstract: A plasma display device having a panel main body in which a pair of transparent substrates is arranged in opposition so as to form a discharge space between the substrates on at least a front side, barrier ribs are arranged on at least one of the substrates to divide the discharge space into a plurality of spaces, a group of electrodes is arranged on the substrates so as to generate discharge in the discharge space divided with the barrier ribs, and phosphor layers that emit by discharge are provided, in which the phosphor layers are equipped with a green phosphor layer including at least Zn2SiO4:Mn, a surface of Zn2SiO4:Mn is coated with magnesium oxide, and a ratio of an Mg element to a Si element on the surface measured with an XPS apparatus is 0.7 to 4.0.

Abstract: The immunoassay method of this invention measures the content of a subject substance in a sample. The method includes the steps of: (a) preparing a mixed solution by mixing the sample and an antibody solution including a first monoclonal antibody and a second monoclonal antibody capable of specifically binding to the subject substance; and (b) measuring an optical property of the mixed solution. The first monoclonal antibody is capable of binding to a first epitope of the subject substance, and the second monoclonal antibody is capable of binding to a second epitope of the subject substance different from the first epitope. Each of the first and second epitopes exists singly in the subject substance.

Abstract: A specific coupling reaction measuring method of this invention for measuring a content of a subject substance in a sample includes the steps of (a) constructing a reaction system including the sample and a magnetic particle on which a specific coupling substance for specifically coupling with the subject substance is immobilized; (b) measuring an optical characteristic of the reaction system; and (c) removing, from the reaction system, an agglutination complex including the subject substance, the specific coupling substance and the magnetic particle by utilizing magnetic force.

Abstract: It is intended to provide an antibody specific to HbA1c, antibody-producing cells capable of supplying the antibody in a stable state in the future, and a method of constructing the antibody-producing cells without any probability factors, and a method which comprises fusing mouse spleen cells, which have been sensitized with an immunogen composed of a compound containing the following structural formula (I) and a binding protein, with a myeloma-origin cell line, obtaining monoclonal antibody-producing cells by cloning, and then purifying and acquiring the monoclonal antibody produced by these cells into the culture supernatant

Abstract: A specific coupling reaction measuring method of this invention for measuring a content of a subject substance in a sample includes the steps of (a) constructing a reaction system including the sample and a magnetic particle on which a specific coupling substance for specifically coupling with the subject substance is immobilized; (b) measuring an optical characteristic of the reaction system; and (c) removing, from the reaction system, an agglutination complex including the subject substance, the specific coupling substance and the magnetic particle by utilizing magnetic force.

Abstract: A vital data utilization system that stores and utilizes measured vital data, including: a vital data measurement unit 101 that measures the vital data of a subject; a time measurement unit 102 that stores the information on the measurement date and time at which the vital data was measured; a subject information storage unit 103 on which subject information including the vital data and the information on the measurement date and time that are associated with each other are stored; a reference information storage unit 104 on which reference information including the vital data and the information on the measurement date and time are stored; a subject variation pattern generation unit that extracts, from the subject information storage unit, the subject information in a specific period that lasts until the vital data that satisfies a first predetermined condition is measured, in the case of the measured vital data satisfies the first predetermined condition; a reference variation pattern generation unit 116 th

Abstract: The data measuring unit 11 measures a subject's blood and urine, and acquires numerical data (S501). The communication control unit 12 transmits the acquired numerical data to the data management apparatus 20 (S502). The overall control unit 14 receives the numerical data from the data measuring apparatus 10 (S503), and analyzes the content of the received numerical data (S504). The overall control unit 14 selects calibration curve data based on the above mentioned analysis result (S505), and calculates health care data (S506). Furthermore, the overall control unit 14 directs the communication control unit 13 to transmit the calculated health care data to the data measuring apparatus 10 (S507). The data measuring apparatus 10 receives the health care data from the data management apparatus 20 (S508).

Abstract: A blood processing method according to the present invention includes Step St1 of preparing a blood specimen sample and a hemolyzing agent, and Step St2 of mixing the blood specimen sample and the hemolyzing agent to prepare a mixture sample. In this case, the hemolyzing agent is a solid reagent for destroying erythrocyte membranes.

Abstract: A specific coupling reaction measuring method of this invention for measuring a content of a subject substance in a sample includes the steps of (a) constructing a reaction system including the sample and a magnetic particle on which a specific coupling substance for specifically coupling with the subject substance is immobilized; (b) measuring an optical characteristic of the reaction system; and (c) removing, from the reaction system, an agglutination complex including the subject substance, the specific coupling substance and the magnetic particle by utilizing magnetic force.

Abstract: The present invention provides a microparticle and a microparticle-labeled protein using that microparticle for use in chromatography. A protein is bound or adsorbed to the microparticle to form a protein complex, i.e., the microparticle-labeled protein. The microparticle has an absorbance (e.g., at least 0.1 under the measurement conditions: the concentration of the microparticle is 1010/ml and the optical path length of the microparticle is 1 cm) measurable for a wavelength of about 650 to about 800 nm, preferably about 400 to about 800 nm, and more preferably at least a partial range (e.g., at a portion in the range, and preferably a wavelength range having a width of at least about 50 nm) within the wavelength range of about 200 nm to about 800 nm, and even more preferably all wavelengths in the wavelength range of about 200 nm to about 800 nm.